The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Evicel



Omrix Biopharmaceuticals S.A.EU/1/08/473/1-3

Main Information

Trade NameEvicel
Active SubstancesHuman fibrinogen
Human thrombin
Dosage FormSolution for sealant
Licence HolderOmrix Biopharmaceuticals S.A.
Licence NumberEU/1/08/473/1-3

Group Information

ATC CodeB02BB Fibrinogen
B02BB01 fibrinogen, human

Status

License statusAuthorised
Licence Issued06/10/2008
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back